Literature DB >> 2020761

The potential of using hyperthermia to eliminate radioresistant hypoxic cells.

J Overgaard1, C Grau, J C Lindegaard, M R Horsman.   

Abstract

It is known that cells in a nutritionally deprived and acidic environment are sensitive to heat. In general these same cells are chronically hypoxic and therefore heat possesses the potential to eliminate (some) of this radioresistant population. A direct radiosensitization is observed when heat is given simultaneously with radiation. This effect occurs to the same extent in both aerobic and hypoxic cells, thus the oxygen enhancement ratio is unchanged. By giving heat several hours after radiation the direct radiosensitization is avoided and the specific heat killing of the acidic, chronically hypoxic, tumor cells may be utilized to improve the therapeutic gain. The current investigation clearly demonstrates this concept in a C3H mammary carcinoma using a local tumor control assay. This effect could be further enhanced by adding hypoxic radiosensitizers (nimorazole, misonidazole) or a blood flow modifier (nicotinamide) which can eliminate acutely hypoxic cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2020761     DOI: 10.1016/0167-8140(91)90197-o

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  4 in total

1.  Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.

Authors:  C Grau; J Overgaard
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  The Effect of Hyperthermia and Radiotherapy Sequence on Cancer Cell Death and the Immune Phenotype of Breast Cancer Cells.

Authors:  Azzaya Sengedorj; Michael Hader; Lukas Heger; Benjamin Frey; Diana Dudziak; Rainer Fietkau; Oliver J Ott; Stephan Scheidegger; Sergio Mingo Barba; Udo S Gaipl; Michael Rückert
Journal:  Cancers (Basel)       Date:  2022-04-19       Impact factor: 6.575

3.  The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N.

Authors:  R Gallagher; C M Hughes; M M Murray; O P Friery; L H Patterson; D G Hirst; S R McKeown
Journal:  Br J Cancer       Date:  2001-08-17       Impact factor: 7.640

Review 4.  Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary?

Authors:  Jan C Peeken; Peter Vaupel; Stephanie E Combs
Journal:  Front Oncol       Date:  2017-06-30       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.